VRI

Sorenson Launches On-Demand ASL Interpreting Through Video Relay Interpreting (VRI) for Enterpreises That Use Microsoft Teams or Zoom Video Communications, Inc.

Retrieved on: 
화요일, 2월 6, 2024
Zoom Video Communications, Language, ASL, Deafblindness, Zoom, Microsoft Teams, Video remote interpreting, VRI, Microsoft, Communication, American Sign Language, Workplace, Organization, Management

SALT LAKE CITY, Feb. 6, 2024 /PRNewswire/ -- Sorenson, the leading provider of inclusive communication services for Deaf, DeafBlind, and hard-of-hearing communities around the world, today launched Sorenson Express, integrations for Microsoft Teams and Zoom Video Communications, Inc.  Sorenson Express is an on-demand American Sign Language (ASL), Video Remote Interpreting (VRI) service for businesses that use Microsoft Teams or Zoom in their enterprises. Sorenson Express for VRI seamlessly integrates interpreters as active video participants into Microsoft Teams or Zoom video meetings and can integrate an ASL interpreter into video meetings on-demand.

Key Points: 
  • Sorenson Express for VRI seamlessly integrates interpreters as active video participants into Microsoft Teams or Zoom video meetings and can integrate an ASL interpreter into video meetings on-demand.
  • Sorenson Express is the first B2B, ASL interpreting service to provide an integrated app experience with Teams and Zoom.
  • The costs associated with Sorenson Express for VRI are undertaken by the business, not for the employee or consumer.
  • Key benefits of using Sorenson Express include:
    Accessibility: Sorenson Express can bridge gaps whenever there's a sudden need for an interpreter that wasn't possible to schedule.

Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer

Retrieved on: 
수요일, 1월 17, 2024
General Health, Medical Devices, Health, Health Technology, Managed Care, Senior, Empowerment, University, VRI, Knowledge, Business administration, Mechanical, Acquisition, Purdue University, Inc., Management

Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Jeff Bennett as Chief Strategy and Innovation Officer and Seth Ravine as Chief Commercial Officer, effective December 2023.

Key Points: 
  • Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Jeff Bennett as Chief Strategy and Innovation Officer and Seth Ravine as Chief Commercial Officer, effective December 2023.
  • “My focus lies in crafting our strategic framework to seamlessly blend digital and personal engagement to empower individuals in their care.
  • With over 25 years of sales experience, Seth has a proven track record of driving innovation and expanding market presence.
  • In his expanded role, Seth will oversee the cross-functional Mobility, Home, and innovation strategy to drive progression in the industry and stimulate growth in untapped markets.

COMCAST LAUNCHES LIVE AMERICAN SIGN LANGUAGE INTERPRETING SERVICES AT SIX GREATER PHILADELPHIA XFINITY STORE LOCATIONS

Retrieved on: 
목요일, 10월 19, 2023
Scranton School for Deaf and Hard-of-Hearing Children, Accessibility, ASL, Vermont Center for the Deaf and Hard of Hearing, CSD, Unit, Organization, PSD, Xfinity, American Community Survey, VRI, Comcast, Communication Service for the Deaf, Student, Partnership, ACS, Pew Research Center, Telecommunications, Digital divide, Disability, American Sign Language, Hearing, Mobile phone, MD, Deafness, Pennsylvania Impressionism

PHILADELPHIA, Oct. 19, 2023 /PRNewswire/ -- As part of its ongoing commitment to digital inclusion and accessibility, Comcast today announced the availability of live American Sign Language (ASL) interpreting services at six Xfinity Store locations in Greater Philadelphia. Customers who need ASL support can stop into any Philadelphia Xfinity Store, where representatives will utilize ASL Video Remote Interpreting (VRI) to access a live interpreter provided by partner, Communication Service for the Deaf (CSD). Comcast is the first telecommunications retailer in the country to offer live, on-demand, remote ASL interpreting services in stores to better serve customers.

Key Points: 
  • PHILADELPHIA, Oct. 19, 2023 /PRNewswire/ -- As part of its ongoing commitment to digital inclusion and accessibility, Comcast today announced the availability of live American Sign Language (ASL) interpreting services at six Xfinity Store locations in Greater Philadelphia.
  • Customers who need ASL support can stop into any Philadelphia Xfinity Store, where representatives will utilize ASL Video Remote Interpreting (VRI) to access a live interpreter provided by partner, Communication Service for the Deaf (CSD).
  • Comcast is the first telecommunications retailer in the country to offer live, on-demand, remote ASL interpreting services in stores to better serve customers.
  • Offering ASL live interpreting services in stores is part of Comcast's ongoing commitment towards closing the digital divide and making its products and services accessible to everyone.

CERTIFIED LANGUAGES INTERNATIONAL LAUNCHES PROPRIETARY VIDEO INTERPRETING PLATFORM

Retrieved on: 
화요일, 10월 10, 2023
Mobile, Organization, Language, Education, HIPAA, LEP, VRI, CLI, Merfy, Insurance, ASL, Patient, American Sign Language, Mobile phone

PORTLAND, Ore., Oct. 10, 2023 /PRNewswire/ -- Certified Languages International (CLI), a leader in the remote interpretation and language services industry, announces the rollout of MERFi™, a proprietary video remote interpreting (VRI) platform, effectively migrating its existing clientele from a third-party VRI service in use since 2013. The embodiment and natural evolution of CLI's highest-quality language access services, MERFi (Mobile, Easy, Reliable, Fast Interpreting) connects users with top-tier video interpreters with the customizations, reliability, and flexibility to provide full-spectrum support. MERFi is HIPAA compliant, secure, and offers video interpreters in 21 spoken languages plus American Sign Language (ASL). Users can also access phone interpreters in 230+ spoken languages with the platform's audio feature. 

Key Points: 
  • PORTLAND, Ore., Oct. 10, 2023 /PRNewswire/ -- Certified Languages International (CLI), a leader in the remote interpretation and language services industry, announces the rollout of MERFi™, a proprietary video remote interpreting (VRI) platform, effectively migrating its existing clientele from a third-party VRI service in use since 2013.
  • The embodiment and natural evolution of CLI's highest-quality language access services, MERFi (Mobile, Easy, Reliable, Fast Interpreting) connects users with top-tier video interpreters with the customizations, reliability, and flexibility to provide full-spectrum support.
  • MERFi is HIPAA compliant, secure, and offers video interpreters in 21 spoken languages plus American Sign Language (ASL).
  • MERFi, an integrated video solution, allows users to seamlessly place video, audio, and multiparty calls through the same web-based device-agnostic platform, significantly benefiting companies and their clientele of limited English proficient (LEP), deaf, and hard-of-hearing individuals.

Republic of Suriname Reaches Agreement in Principle with Euronote Creditor Committee on Debt Restructuring Terms

Retrieved on: 
수요일, 5월 3, 2023
Block, Ministry of Finance and Planning (Tanzania), Bond, SEC Rule 144A, Person, Sale, VRI, Committee, Bond (finance), Ministry, Republic, SLA, White, Regulation, IMF, Security (finance)

The five members of the Committee currently own or control approximately 75% of the outstanding Bonds.

Key Points: 
  • The five members of the Committee currently own or control approximately 75% of the outstanding Bonds.
  • The VRI will only pay out in the event such royalty revenues in fact materialize for the Republic.
  • The Restructuring will be implemented through an exchange offer and consent solicitation.
  • Implementation of the Restructuring remains subject to agreement between the Republic and the Committee on the definitive legal documentation for the New Bond, the VRI and exchange offer and consent solicitation.

Republic of Suriname Reaches Agreement in Principle with Euronote Creditor Committee on Debt Restructuring Terms

Retrieved on: 
수요일, 5월 3, 2023
Block, Ministry of Finance and Planning (Tanzania), Bond, SEC Rule 144A, Person, Sale, VRI, Committee, Bond (finance), Ministry, Republic, SLA, White, Regulation, IMF, Security (finance)

The five members of the Committee currently own or control approximately 75% of the outstanding Bonds.

Key Points: 
  • The five members of the Committee currently own or control approximately 75% of the outstanding Bonds.
  • The VRI will only pay out in the event such royalty revenues in fact materialize for the Republic.
  • The Restructuring will be implemented through an exchange offer and consent solicitation.
  • Implementation of the Restructuring remains subject to agreement between the Republic and the Committee on the definitive legal documentation for the New Bond, the VRI and exchange offer and consent solicitation.

LinKinVax Introduces its Scientific Advisory Board with the Appointment of Three Leading Experts in Immunology and Epidemiology

Retrieved on: 
수요일, 4월 26, 2023
Biotechnology, Other Health, Health, Pharmaceutical, Biometrics, Oncology, Other Science, Research, Infectious Diseases, Science, Clinical Trials, Vaccine, Immunization, Male, Hepatitis, International, Female, University, Journal of the International AIDS Society, HIV, Infection, COVID-19, DC, ANRS, Coronavirus Scientific Advisory Board, Woman, H. Lee Moffitt Cancer Center & Research Institute, Lausanne University Hospital, Doctor of Philosophy, Doherty Institute, CHUV, VRI, HIV Vaccine Trials Network, Cervical cancer, Patient, Helmholtz Centre for Infection Research, HIV/AIDS, HPV, Entrepreneurship, HVTN, Research institute, Immunology, Australian Academy of Health and Medical Sciences, Epidemiology, Laboratory, FRACP, Medicine, Cancer, Immunity

LinKinVax, a clinical-stage biotechnology company, announces the creation of its Scientific Advisory Board with the appointment of three experts in immunology and epidemiology.

Key Points: 
  • LinKinVax, a clinical-stage biotechnology company, announces the creation of its Scientific Advisory Board with the appointment of three experts in immunology and epidemiology.
  • “We are delighted to welcome Prof. Anna Giuliano, Prof. Sharon Lewin and Prof. Giuseppe Pantaleo to our Scientific Advisory Board.
  • “We are very pleased to have convinced these leading experts to join our scientific committee.
  • Their skills and experience in immunology and epidemiology will help guide and optimise all aspects of our clinical development plans for our DC-targeting vaccine platform.

Children's Hospital of Philadelphia Receives $10 Million Grant from the Gilbert Family Foundation to Accelerate Neurofibromatosis Research

Retrieved on: 
화요일, 4월 4, 2023
LGG, NF, Brain, Executive, Gene, CHOP, Prevalence, Genetics, Neuro-Oncology (journal), Elective surgery, Pediatrics, Neoplasm, Section, Heredity, HGAP, Hope, Neurofibromatosis, Research, Immunotherapy, VRI, Pain, CAR, Disorder, Neuro-ophthalmology, Genetic disorder, Standard of care, Patient, Investment, Neuro-oncology, HGG, Ophthalmology, Infant, Paratriathlon, NF1, Family, Neurology, BTI, Vision restoration therapy, Disease, Medical imaging, Pharmaceutical industry

PHILADELPHIA, April 4, 2023 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) today announced that it has received more than $10 million in a series of gifts to fund critical neurofibromatosis research from the Gilbert Family Foundation, a private foundation established by Dan and Jennifer Gilbert to accelerate a cure for neurofibromatosis type 1 (NF1). 

Key Points: 
  • The tumors that develop in the brain and body can lead to serious complications, including vision loss and severe pain.
  • The Gilbert Family Foundation was founded in 2015 to help accelerate a cure for NF1.
  • Nick Gilbert, the oldest son of Dan and Jennifer Gilbert, was diagnosed with NF1 as an infant and continues to battle the disease.
  • CHOP has received previous investments for its promising research as part of the Gilbert Family Foundation's Vision Restoration Initiative (VRI).

LinKinVax Welcomes Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate

Retrieved on: 
수요일, 2월 22, 2023
AIDS, Health, Infectious Diseases, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Safety, HIV, Antibody, Volunteering, CD40, ANRS, Week, Immune system, Risk, Research, VRI, INSERM, Vaccination, RV144, Male, Env, B cell, CMSO, HIV/AIDS, Education, Phase, Pharmaceutical industry, Vaccine

LinKinVax, a clinical-stage biotechnology company, welcomes the interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine and conducted by the sponsor INSERM-ANRS and the Vaccine Research Institute (ANRS and Université Paris-Est Créteil, France).

Key Points: 
  • LinKinVax, a clinical-stage biotechnology company, welcomes the interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine and conducted by the sponsor INSERM-ANRS and the Vaccine Research Institute (ANRS and Université Paris-Est Créteil, France).
  • These results show that the vaccine candidate is safe and induces an early, significant and sustained immune response.
  • The CD40.HIVRI.Env vaccine candidate is developed by the VRI with a technology whose exclusive worldwide license is held by LinKinVax.
  • This important milestone paves the way for the upcoming Phase II/III clinical studies that we will conduct once the final Phase I results have been obtained.

LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M 

Retrieved on: 
월요일, 1월 9, 2023
Oncology, Health, Infectious Diseases, COVID-19, Clinical Trials, Pharmaceutical, Biotechnology, Ooredoo, PIA, HPV, B cell, University, Coronaviridae, Biomedical Research, Chlamydia, HIV, Public health, Vaccine Research Center, Government, Vaccine, VRI, Infection, Immune system, UPEC, IQT, Cancer, IMRB, University of Paris-Est Marne-la-Vallée

LinKinVax’s innovative technology directly targets dendritic cells (“DC”), which play a crucial role in the immune system, stimulating and regulating immune responses.

Key Points: 
  • LinKinVax’s innovative technology directly targets dendritic cells (“DC”), which play a crucial role in the immune system, stimulating and regulating immune responses.
  • It is predicated on work by the Vaccine Research Institute/Inserm (VRI) in which Inserm, University of Paris Est Créteil (UPEC), and the Mondor Institute of Biomedical Research (IMRB) participate.
  • Englehart, Director, IQT International Ltd UK: “We are impressed by LinKinVax’s team and its vision for developing world-class vaccine technology.
  • This new financing, completed in December 2022, includes a seed funding from private shareholders, beginning of 2022.